COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa.

Sanyang, Bakary; Kanteh, Abdoulie; Usuf, Effua; Nadjm, Behzad; Jarju, Sheikh; Bah, Alasana; Bojang, Abdoulie; Grey-Johnson, Mary; Jones, Joquina Chiquita; Gai, Abdou; +12 more... Sarr, Catherine; Sillah, Fatoumata; Wariri, Oghenebrume; Oko, Francis; Cerami, Carla; Forrest, Karen; Sey, Alhagie Papa; Jallow, Haruna; Nwakanma, Davis; Sesay, Abdul Karim; D'Alessandro, Umberto; Roca, Anna; (2021) COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa. The Lancet Global health, 9 (7). e905-e907. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(21)00213-8

Abstract

At the beginning of the COVID-19 pandemic, in early 2020, the scientific community hypothesised that SARS-CoV-2 transmission would eventually be hindered by herd immunity, conferred by natural infection, vaccination, or both.1 However, essential questions about whether infection with SARS-CoV-2 confers protection against reinfection and the length of time the protection lasts after either infection or vaccination remain open. These answers are crucial for the development of appropriate health control measures worldwide and become more important as new viral variants spread.

Additional Information

Item Type	Article
Faculty and Department	Faculty of Infectious and Tropical Diseases > Dept of Disease Control MRC Gambia > GM-Disease Control and Elimination Theme Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology & International Health (2023-) MRC Gambia > GM-Nutrition Theme MRC Gambia > GM-General Administration MRC Gambia > Child Survival Theme MRC Gambia > GM-Gambia Clinical Services/Comms
Research Centre	Covid-19 Research
PubMed ID	34090610
Elements ID	161525